##gff-version 3
##sequence-region P38398 1 1863
P38398	UniProtKB	Chain	1	1863	.	.	.	ID=PRO_0000055830;Note=Breast cancer type 1 susceptibility protein	
P38398	UniProtKB	Domain	1642	1736	.	.	.	Note=BRCT 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00033	
P38398	UniProtKB	Domain	1756	1855	.	.	.	Note=BRCT 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00033	
P38398	UniProtKB	Zinc finger	24	65	.	.	.	Note=RING-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00175	
P38398	UniProtKB	Region	1397	1424	.	.	.	Note=Interaction with PALB2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19369211;Dbxref=PMID:19369211	
P38398	UniProtKB	Compositional bias	651	654	.	.	.	Note=Poly-Lys	
P38398	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22814378;Dbxref=PMID:22814378	
P38398	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:21406692,PMID:23186163	
P38398	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphoserine%3B by AURKA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14990569;Dbxref=PMID:14990569	
P38398	UniProtKB	Modified residue	395	395	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332;Dbxref=PMID:18669648,PMID:19690332	
P38398	UniProtKB	Modified residue	398	398	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332;Dbxref=PMID:18669648,PMID:19690332	
P38398	UniProtKB	Modified residue	423	423	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
P38398	UniProtKB	Modified residue	434	434	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Modified residue	551	551	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Modified residue	694	694	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:23186163	
P38398	UniProtKB	Modified residue	708	708	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Modified residue	725	725	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48754	
P38398	UniProtKB	Modified residue	753	753	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
P38398	UniProtKB	Modified residue	840	840	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48754	
P38398	UniProtKB	Modified residue	988	988	.	.	.	Note=Phosphoserine%3B by CHEK2;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10724175,ECO:0000269|PubMed:20364141;Dbxref=PMID:10724175,PMID:20364141	
P38398	UniProtKB	Modified residue	1009	1009	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Modified residue	1143	1143	.	.	.	Note=Phosphoserine%3B by ATR%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Modified residue	1189	1189	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Modified residue	1191	1191	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Modified residue	1211	1211	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
P38398	UniProtKB	Modified residue	1217	1217	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
P38398	UniProtKB	Modified residue	1218	1218	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:21406692;Dbxref=PMID:18669648,PMID:21406692	
P38398	UniProtKB	Modified residue	1280	1280	.	.	.	Note=Phosphoserine%3B by ATR%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Modified residue	1328	1328	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
P38398	UniProtKB	Modified residue	1336	1336	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692;Dbxref=PMID:17081983,PMID:20068231,PMID:21406692	
P38398	UniProtKB	Modified residue	1342	1342	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692;Dbxref=PMID:20068231,PMID:21406692	
P38398	UniProtKB	Modified residue	1387	1387	.	.	.	Note=Phosphoserine%3B by ATM and ATR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Modified residue	1394	1394	.	.	.	Note=Phosphothreonine%3B by ATR%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Modified residue	1423	1423	.	.	.	Note=Phosphoserine%3B by ATM and ATR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Modified residue	1457	1457	.	.	.	Note=Phosphoserine%3B by ATR%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Modified residue	1524	1524	.	.	.	Note=Phosphoserine%3B by ATM;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21144835;Dbxref=PMID:21144835	
P38398	UniProtKB	Modified residue	1542	1542	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Cross-link	109	109	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P38398	UniProtKB	Cross-link	301	301	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P38398	UniProtKB	Cross-link	339	339	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:28112733	
P38398	UniProtKB	Cross-link	443	443	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:28112733;Dbxref=PMID:25755297,PMID:28112733	
P38398	UniProtKB	Cross-link	459	459	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:28112733	
P38398	UniProtKB	Cross-link	519	519	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P38398	UniProtKB	Cross-link	583	583	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:28112733	
P38398	UniProtKB	Cross-link	654	654	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25218447;Dbxref=PMID:25218447	
P38398	UniProtKB	Cross-link	734	734	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25218447;Dbxref=PMID:25218447	
P38398	UniProtKB	Cross-link	739	739	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25218447;Dbxref=PMID:25218447	
P38398	UniProtKB	Cross-link	918	918	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P38398	UniProtKB	Cross-link	987	987	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P38398	UniProtKB	Cross-link	1079	1079	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P38398	UniProtKB	Alternative sequence	1	47	.	.	.	ID=VSP_057569;Note=In isoform 8. Missing	
P38398	UniProtKB	Alternative sequence	1	17	.	.	.	ID=VSP_035396;Note=In isoform 4. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Alternative sequence	64	1863	.	.	.	ID=VSP_047891;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.4	
P38398	UniProtKB	Alternative sequence	224	1365	.	.	.	ID=VSP_035398;Note=In isoform 5. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Alternative sequence	264	1366	.	.	.	ID=VSP_035399;Note=In isoform 3 and isoform 6. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:9010228;Dbxref=PMID:15489334,PMID:9010228	
P38398	UniProtKB	Alternative sequence	1453	1453	.	.	.	ID=VSP_043797;Note=In isoform 3 and isoform 6. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:9010228;Dbxref=PMID:15489334,PMID:9010228	
P38398	UniProtKB	Alternative sequence	1453	1453	.	.	.	ID=VSP_055404;Note=In isoform 7. A->DSHIHGQRNNSMFSKRPREHIS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
P38398	UniProtKB	Alternative sequence	1778	1863	.	.	.	ID=VSP_043798;Note=In isoform 6. DQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIPHSHY->GCPPNCGCAARCLDRGQWLPCNWADV;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
P38398	UniProtKB	Natural variant	4	4	.	.	.	ID=VAR_070458;Note=In BC%3B unknown pathological significance. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs786203152,PMID:23867111	
P38398	UniProtKB	Natural variant	10	10	.	.	.	ID=VAR_020679;Note=In BC and BROVCA1. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_007754;Note=Found in breast-ovarian cancer patients%3B unknown pathological significance. V->A;Dbxref=dbSNP:rs80357017	
P38398	UniProtKB	Natural variant	18	18	.	.	.	ID=VAR_063899;Note=In BC%3B unknown pathological significance. M->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356929,PMID:17924331,PMID:23867111	
P38398	UniProtKB	Natural variant	21	21	.	.	.	ID=VAR_007755;Note=Found in breast-ovarian cancer patients%3B unknown pathological significance. I->V;Dbxref=dbSNP:rs80357406	
P38398	UniProtKB	Natural variant	22	22	.	.	.	ID=VAR_007756;Note=In BC. L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs80357438,PMID:9609997	
P38398	UniProtKB	Natural variant	23	23	.	.	.	ID=VAR_020680;Note=In BC and BROVCA1. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	30	30	.	.	.	ID=VAR_035947;Note=In a breast cancer sample%3B somatic mutation. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
P38398	UniProtKB	Natural variant	45	45	.	.	.	ID=VAR_070459;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs769650474,PMID:23867111	
P38398	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_007757;Note=In BC and ovarian cancer%3B no interaction with BAP1. C->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12938098,ECO:0000269|PubMed:14746861,ECO:0000269|PubMed:23867111,ECO:0000269|PubMed:7894493,ECO:0000269|PubMed:8554067,ECO:0000269|PubMed:9528852,ECO:0000269|PubMed:9760198;Dbxref=dbSNP:rs28897672,PMID:12938098,PMID:14746861,PMID:23867111,PMID:7894493,PMID:8554067,PMID:9528852,PMID:9760198	
P38398	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_007758;Note=In BC%3B no interaction with BAP1. C->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23867111,ECO:0000269|PubMed:7894491,ECO:0000269|PubMed:9482581,ECO:0000269|PubMed:9528852;Dbxref=dbSNP:rs80357064,PMID:23867111,PMID:7894491,PMID:9482581,PMID:9528852	
P38398	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_007759;Note=C->Y;Dbxref=dbSNP:rs55851803	
P38398	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_070460;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357102,PMID:23867111	
P38398	UniProtKB	Natural variant	71	71	.	.	.	ID=VAR_020681;Note=In BC%3B unknown pathological significance. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs80356913,PMID:12938098	
P38398	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_070461;Note=Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897673,PMID:23867111	
P38398	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_070462;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357413,PMID:23867111	
P38398	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_070463;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. P->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs55971303,PMID:23867111	
P38398	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_070464;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs748876625,PMID:23867111	
P38398	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_052077;Note=S->R;Dbxref=dbSNP:rs28897674	
P38398	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_070465;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_070466;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357325,PMID:23867111	
P38398	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_070467;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs55688530,PMID:23867111	
P38398	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_070468;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357090,PMID:23867111	
P38398	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_008759;Note=In ovarian cancer%3B unknown pathological significance. E->K	
P38398	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_070469;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357001,PMID:23867111	
P38398	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_007760;Note=H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9010228,ECO:0000269|PubMed:9760198;Dbxref=dbSNP:rs80357396,PMID:9010228,PMID:9760198	
P38398	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_070470;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356865,PMID:23867111	
P38398	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_070471;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897675,PMID:23867111	
P38398	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_070472;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. V->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357244,PMID:23867111	
P38398	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_007761;Note=In BC. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8723683;Dbxref=dbSNP:rs80357244,PMID:8723683	
P38398	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_019944;Note=G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.6;Dbxref=dbSNP:rs8176153	
P38398	UniProtKB	Natural variant	346	346	.	.	.	ID=VAR_008760;Note=In BC%3B unknown pathological significance. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10323242;Dbxref=dbSNP:rs80357015,PMID:10323242	
P38398	UniProtKB	Natural variant	356	356	.	.	.	ID=VAR_007762;Note=Common polymorphism. Q->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7894493,ECO:0000269|Ref.5,ECO:0000269|Ref.6;Dbxref=dbSNP:rs1799950,PMID:7894493	
P38398	UniProtKB	Natural variant	369	369	.	.	.	ID=VAR_007763;Note=In BC. Missing	
P38398	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_007764;Note=I->M;Dbxref=dbSNP:rs56128296	
P38398	UniProtKB	Natural variant	461	461	.	.	.	ID=VAR_007765;Note=In BC. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs56046357,PMID:9609997	
P38398	UniProtKB	Natural variant	465	465	.	.	.	ID=VAR_007766;Note=In BC. Y->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs397508869,PMID:9609997	
P38398	UniProtKB	Natural variant	507	507	.	.	.	ID=VAR_007767;Note=Found in breast-ovarian cancer patients%3B unknown pathological significance. R->I;Dbxref=dbSNP:rs80357224	
P38398	UniProtKB	Natural variant	552	552	.	.	.	ID=VAR_007768;Note=In BC. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs397508893,PMID:9609997	
P38398	UniProtKB	Natural variant	656	656	.	.	.	ID=VAR_020682;Note=N->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12442274;Dbxref=PMID:12442274	
P38398	UniProtKB	Natural variant	668	668	.	.	.	ID=VAR_070473;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357250,PMID:23867111	
P38398	UniProtKB	Natural variant	693	693	.	.	.	ID=VAR_007769;Note=Rare polymorphism. D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15026808,ECO:0000269|Ref.6;Dbxref=dbSNP:rs4986850,PMID:15026808	
P38398	UniProtKB	Natural variant	695	695	.	.	.	ID=VAR_070474;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897681,PMID:23867111	
P38398	UniProtKB	Natural variant	723	723	.	.	.	ID=VAR_020110;Note=N->D;Dbxref=dbSNP:rs4986845	
P38398	UniProtKB	Natural variant	749	749	.	.	.	ID=VAR_020683;Note=In BC. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12442275;Dbxref=dbSNP:rs80357114,PMID:12442275	
P38398	UniProtKB	Natural variant	758	758	.	.	.	ID=VAR_035948;Note=In a breast cancer sample%3B somatic mutation. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
P38398	UniProtKB	Natural variant	772	772	.	.	.	ID=VAR_007770;Note=Rare polymorphism. V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7894491,ECO:0000269|PubMed:9482581;Dbxref=dbSNP:rs80357467,PMID:7894491,PMID:9482581	
P38398	UniProtKB	Natural variant	778	778	.	.	.	ID=VAR_035949;Note=In a breast cancer sample%3B somatic mutation. G->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
P38398	UniProtKB	Natural variant	798	798	.	.	.	ID=VAR_070475;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs876660005,PMID:23867111	
P38398	UniProtKB	Natural variant	810	810	.	.	.	ID=VAR_070476;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. N->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897682,PMID:23867111	
P38398	UniProtKB	Natural variant	820	820	.	.	.	ID=VAR_007771;Note=Rare polymorphism. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9482581;Dbxref=dbSNP:rs56082113,PMID:9482581	
P38398	UniProtKB	Natural variant	826	826	.	.	.	ID=VAR_007772;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. T->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897683,PMID:23867111	
P38398	UniProtKB	Natural variant	835	835	.	.	.	ID=VAR_020684;Note=In BROVCA1%3B unknown pathological significance. H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs751656678,PMID:12938098	
P38398	UniProtKB	Natural variant	841	841	.	.	.	ID=VAR_070477;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357337,PMID:23867111	
P38398	UniProtKB	Natural variant	841	841	.	.	.	ID=VAR_007773;Note=In BROVCA1%3B unknown pathological significance. R->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8968716,ECO:0000269|PubMed:9760198;Dbxref=dbSNP:rs1800709,PMID:8968716,PMID:9760198	
P38398	UniProtKB	Natural variant	856	856	.	.	.	ID=VAR_020685;Note=In a patient with sporadic breast cancer%3B unknown pathological significance. Y->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15365993,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356892,PMID:15365993,PMID:23867111	
P38398	UniProtKB	Natural variant	866	866	.	.	.	ID=VAR_070478;Note=R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs41286300,PMID:23867111	
P38398	UniProtKB	Natural variant	866	866	.	.	.	ID=VAR_020686;Note=In BC%3B unknown pathological significance. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=PMID:12938098	
P38398	UniProtKB	Natural variant	871	871	.	.	.	ID=VAR_007774;Note=Common polymorphism. P->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10323242,ECO:0000269|PubMed:12442274,ECO:0000269|PubMed:15365993,ECO:0000269|PubMed:15489334,ECO:0000269|Ref.6;Dbxref=dbSNP:rs799917,PMID:10323242,PMID:12442274,PMID:15365993,PMID:15489334	
P38398	UniProtKB	Natural variant	888	888	.	.	.	ID=VAR_020687;Note=In BC%3B unknown pathological significance. H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs80357480,PMID:12938098	
P38398	UniProtKB	Natural variant	892	892	.	.	.	ID=VAR_007775;Note=In BC. L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs397508994,PMID:9609997	
P38398	UniProtKB	Natural variant	903	1863	.	.	.	ID=VAR_080693;Note=In FANCS. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29133208;Dbxref=PMID:29133208	
P38398	UniProtKB	Natural variant	925	925	.	.	.	ID=VAR_021913;Note=I->L;Dbxref=dbSNP:rs4986847	
P38398	UniProtKB	Natural variant	960	960	.	.	.	ID=VAR_007776;Note=In BC. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs397509022,PMID:9609997	
P38398	UniProtKB	Natural variant	989	989	.	.	.	ID=VAR_020111;Note=F->S;Dbxref=dbSNP:rs4986848	
P38398	UniProtKB	Natural variant	1008	1008	.	.	.	ID=VAR_007777;Note=Common polymorphism. M->I;Dbxref=dbSNP:rs1800704	
P38398	UniProtKB	Natural variant	1025	1025	.	.	.	ID=VAR_007778;Note=In BC. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs397509034,PMID:9609997	
P38398	UniProtKB	Natural variant	1038	1038	.	.	.	ID=VAR_007779;Note=Common polymorphism. E->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10323242,ECO:0000269|PubMed:15365993,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:7894493,ECO:0000269|Ref.6;Dbxref=dbSNP:rs16941,PMID:10323242,PMID:15365993,PMID:15489334,PMID:7894493	
P38398	UniProtKB	Natural variant	1040	1040	.	.	.	ID=VAR_007780;Note=Rare polymorphism. S->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15026808,ECO:0000269|PubMed:7894491,ECO:0000269|PubMed:7894493,ECO:0000269|PubMed:9482581,ECO:0000269|Ref.6;Dbxref=dbSNP:rs4986852,PMID:15026808,PMID:7894491,PMID:7894493,PMID:9482581	
P38398	UniProtKB	Natural variant	1047	1047	.	.	.	ID=VAR_007781;Note=In BC. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs397509037,PMID:9609997	
P38398	UniProtKB	Natural variant	1060	1060	.	.	.	ID=VAR_020688;Note=E->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15026808,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357184,PMID:15026808,PMID:23867111	
P38398	UniProtKB	Natural variant	1101	1101	.	.	.	ID=VAR_070479;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs41293447,PMID:23867111	
P38398	UniProtKB	Natural variant	1139	1139	.	.	.	ID=VAR_020689;Note=In BC%3B unknown pathological significance. S->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs80357228,PMID:12938098	
P38398	UniProtKB	Natural variant	1140	1140	.	.	.	ID=VAR_019945;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23867111,ECO:0000269|Ref.6;Dbxref=dbSNP:rs2227945,PMID:23867111	
P38398	UniProtKB	Natural variant	1140	1140	.	.	.	ID=VAR_070480;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1150	1150	.	.	.	ID=VAR_007782;Note=In BC. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8723683;Dbxref=dbSNP:rs80357272,PMID:8723683	
P38398	UniProtKB	Natural variant	1183	1183	.	.	.	ID=VAR_007783;Note=Common polymorphism. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10323242,ECO:0000269|PubMed:14722926,ECO:0000269|PubMed:15365993,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:7894493,ECO:0000269|Ref.6;Dbxref=dbSNP:rs16942,PMID:10323242,PMID:14722926,PMID:15365993,PMID:15489334,PMID:7894493	
P38398	UniProtKB	Natural variant	1187	1187	.	.	.	ID=VAR_020690;Note=In BC and BROVCA1. S->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	1200	1200	.	.	.	ID=VAR_020691;Note=In BC and BROVCA1. Q->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=dbSNP:rs56214134,PMID:14722926	
P38398	UniProtKB	Natural variant	1204	1204	.	.	.	ID=VAR_020692;Note=In BC. R->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	1207	1207	.	.	.	ID=VAR_020693;Note=In BC. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	1210	1210	.	.	.	ID=VAR_020694;Note=In BC%3B unknown pathological significance. E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs1060502347,PMID:12938098	
P38398	UniProtKB	Natural variant	1214	1214	.	.	.	ID=VAR_070481;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356923,PMID:23867111	
P38398	UniProtKB	Natural variant	1217	1217	.	.	.	ID=VAR_020695;Note=In BC and BROVCA1. S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	1219	1219	.	.	.	ID=VAR_007784;Note=Found in breast-ovarian cancer patients%3B unknown pathological significance. E->D;Dbxref=dbSNP:rs80356876	
P38398	UniProtKB	Natural variant	1226	1226	.	.	.	ID=VAR_020696;Note=In BROVCA1. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	1236	1236	.	.	.	ID=VAR_052078;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897687,PMID:23867111	
P38398	UniProtKB	Natural variant	1243	1243	.	.	.	ID=VAR_020697;Note=In BROVCA1. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	1250	1250	.	.	.	ID=VAR_052079;Note=E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897686,PMID:23867111	
P38398	UniProtKB	Natural variant	1267	1267	.	.	.	ID=VAR_070482;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs587782190,PMID:23867111	
P38398	UniProtKB	Natural variant	1282	1282	.	.	.	ID=VAR_070483;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. E->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357217,PMID:23867111	
P38398	UniProtKB	Natural variant	1297	1297	.	.	.	ID=VAR_020698;Note=In BC%3B unknown pathological significance. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs1450793674,PMID:12938098	
P38398	UniProtKB	Natural variant	1297	1297	.	.	.	ID=VAR_070484;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1301	1301	.	.	.	ID=VAR_070485;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs273900719,PMID:23867111	
P38398	UniProtKB	Natural variant	1346	1346	.	.	.	ID=VAR_070486;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357407,PMID:23867111	
P38398	UniProtKB	Natural variant	1347	1347	.	.	.	ID=VAR_007785;Note=R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12215251;Dbxref=dbSNP:rs28897689,PMID:12215251	
P38398	UniProtKB	Natural variant	1378	1378	.	.	.	ID=VAR_070487;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897690,PMID:23867111	
P38398	UniProtKB	Natural variant	1400	1400	.	.	.	ID=VAR_070488;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357306,PMID:23867111	
P38398	UniProtKB	Natural variant	1406	1406	.	.	.	ID=VAR_008761;Note=Polymorphism. K->N;Dbxref=dbSNP:rs1800707	
P38398	UniProtKB	Natural variant	1407	1407	.	.	.	ID=VAR_070489;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357492,PMID:23867111	
P38398	UniProtKB	Natural variant	1411	1411	.	.	.	ID=VAR_020699;Note=In BC and ovarian cancer%3B unknown pathological significance%3B decreased interaction with PALB2. M->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14746861,ECO:0000269|PubMed:19369211,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs273900729,PMID:14746861,PMID:19369211,PMID:23867111	
P38398	UniProtKB	Natural variant	1431	1431	.	.	.	ID=VAR_007786;Note=S->P	
P38398	UniProtKB	Natural variant	1443	1443	.	.	.	ID=VAR_007787;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. R->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23867111,ECO:0000269|PubMed:7894491,ECO:0000269|PubMed:9482581;Dbxref=dbSNP:rs41293455,PMID:23867111,PMID:7894491,PMID:9482581	
P38398	UniProtKB	Natural variant	1443	1443	.	.	.	ID=VAR_020112;Note=R->Q;Dbxref=dbSNP:rs4986849	
P38398	UniProtKB	Natural variant	1448	1448	.	.	.	ID=VAR_070490;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357486,PMID:23867111	
P38398	UniProtKB	Natural variant	1486	1486	.	.	.	ID=VAR_070491;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs397507232,PMID:23867111	
P38398	UniProtKB	Natural variant	1495	1495	.	.	.	ID=VAR_063900;Note=In BC%3B unknown pathological significance. R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80357389,PMID:17924331	
P38398	UniProtKB	Natural variant	1512	1512	.	.	.	ID=VAR_007788;Note=S->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12215251,ECO:0000269|PubMed:9482581,ECO:0000269|PubMed:9760198;Dbxref=dbSNP:rs1800744,PMID:12215251,PMID:9482581,PMID:9760198	
P38398	UniProtKB	Natural variant	1534	1534	.	.	.	ID=VAR_070492;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs55815649,PMID:23867111	
P38398	UniProtKB	Natural variant	1561	1561	.	.	.	ID=VAR_007789;Note=Found in breast cancer%3B unknown pathological significance. T->I;Dbxref=dbSNP:rs56158747	
P38398	UniProtKB	Natural variant	1589	1589	.	.	.	ID=VAR_070493;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1606	1606	.	.	.	ID=VAR_007790;Note=Found in breast cancer%3B unknown pathological significance. K->E;Dbxref=dbSNP:rs80356943	
P38398	UniProtKB	Natural variant	1613	1613	.	.	.	ID=VAR_007791;Note=Common polymorphism. S->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10323242,ECO:0000269|PubMed:12442274,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:7894493,ECO:0000269|PubMed:9010228,ECO:0000269|Ref.6;Dbxref=dbSNP:rs1799966,PMID:10323242,PMID:12442274,PMID:15489334,PMID:7894493,PMID:9010228	
P38398	UniProtKB	Natural variant	1620	1620	.	.	.	ID=VAR_019946;Note=T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.6;Dbxref=dbSNP:rs8176219	
P38398	UniProtKB	Natural variant	1623	1623	.	.	.	ID=VAR_063901;Note=Could be associated with cancer susceptibility%3B major splicing aberration identified with this mutant. A->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:20513136;Dbxref=dbSNP:rs80356862,PMID:17924331,PMID:20513136	
P38398	UniProtKB	Natural variant	1628	1628	.	.	.	ID=VAR_007793;Note=In some patients with sporadic breast cancer%3B unknown pathological significance. M->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15365993,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs4986854,PMID:15365993,PMID:23867111	
P38398	UniProtKB	Natural variant	1628	1628	.	.	.	ID=VAR_007792;Note=Found in breast and ovarian cancer patients%3B unknown pathological significance. M->V;Dbxref=dbSNP:rs80357465	
P38398	UniProtKB	Natural variant	1637	1637	.	.	.	ID=VAR_007794;Note=Rare polymorphism. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7939630,ECO:0000269|PubMed:9482581;Dbxref=dbSNP:rs80357048,PMID:7939630,PMID:9482581	
P38398	UniProtKB	Natural variant	1641	1641	.	.	.	ID=VAR_008762;Note=In ovarian cancer%3B unknown pathological significance. A->P;Dbxref=dbSNP:rs1800726	
P38398	UniProtKB	Natural variant	1651	1651	.	.	.	ID=VAR_070494;Note=In BC%3B unknown pathological significance. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356938,PMID:23867111	
P38398	UniProtKB	Natural variant	1651	1651	.	.	.	ID=VAR_070495;Note=In BC%3B unknown pathological significance. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs879254042,PMID:23867111	
P38398	UniProtKB	Natural variant	1652	1652	.	.	.	ID=VAR_007795;Note=Rare polymorphism. M->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12215251,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:23867111,ECO:0000269|PubMed:9482581;Dbxref=dbSNP:rs1799967,PMID:12215251,PMID:15489334,PMID:23867111,PMID:9482581	
P38398	UniProtKB	Natural variant	1655	1655	.	.	.	ID=VAR_070496;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357390,PMID:23867111	
P38398	UniProtKB	Natural variant	1662	1662	.	.	.	ID=VAR_052080;Note=F->C;Dbxref=dbSNP:rs28897695	
P38398	UniProtKB	Natural variant	1665	1665	.	.	.	ID=VAR_020700;Note=V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15026808;Dbxref=dbSNP:rs80357169,PMID:15026808	
P38398	UniProtKB	Natural variant	1685	1685	.	.	.	ID=VAR_063902;Note=In BC%3B unknown pathological significance. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80356890,PMID:17924331	
P38398	UniProtKB	Natural variant	1685	1685	.	.	.	ID=VAR_063903;Note=Could be associated with cancer susceptibility%3B multifactorial likelihood analysis provides evidence for pathogenicity. T->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:20513136;Dbxref=dbSNP:rs80357043,PMID:17924331,PMID:20513136	
P38398	UniProtKB	Natural variant	1686	1686	.	.	.	ID=VAR_070497;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs397509218,PMID:23867111	
P38398	UniProtKB	Natural variant	1686	1686	.	.	.	ID=VAR_070498;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs730882166,PMID:23867111	
P38398	UniProtKB	Natural variant	1688	1688	.	.	.	ID=VAR_070499;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1689	1689	.	.	.	ID=VAR_063904;Note=In BC%3B unknown pathological significance. M->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80357061,PMID:17924331	
P38398	UniProtKB	Natural variant	1690	1690	.	.	.	ID=VAR_020701;Note=In some patients with sporadic breast cancer%3B unknown pathological significance. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15365993;Dbxref=dbSNP:rs397507239,PMID:15365993	
P38398	UniProtKB	Natural variant	1691	1691	.	.	.	ID=VAR_070500;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357034,PMID:23867111	
P38398	UniProtKB	Natural variant	1692	1692	.	.	.	ID=VAR_008763;Note=In ovarian cancer%3B unknown pathological significance. D->N;Dbxref=dbSNP:rs80187739	
P38398	UniProtKB	Natural variant	1697	1697	.	.	.	ID=VAR_020702;Note=In ovarian cancer. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14746861;Dbxref=dbSNP:rs80356993,PMID:14746861	
P38398	UniProtKB	Natural variant	1699	1699	.	.	.	ID=VAR_070501;Note=In BC%3B unknown pathological significance%3B strongly reduces affinity for a BRIP1 phosphopeptide%3B functionally impaired in vitro. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21473589,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs41293459,PMID:21473589,PMID:23867111	
P38398	UniProtKB	Natural variant	1699	1699	.	.	.	ID=VAR_075666;Note=In BC%2C ovarian cancer and FANCS%3B impairs protein stability%3B functionally impaired in vitro. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14746861,ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:21473589,ECO:0000269|PubMed:23867111,ECO:0000269|PubMed:25472942;Dbxref=dbSNP:rs55770810,PMID:14746861,PMID:17924331,PMID:21473589,PMID:23867111,PMID:25472942	
P38398	UniProtKB	Natural variant	1706	1706	.	.	.	ID=VAR_070502;Note=In BC%3B unknown pathological significance. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356860,PMID:23867111	
P38398	UniProtKB	Natural variant	1706	1706	.	.	.	ID=VAR_063905;Note=In BC%3B unknown pathological significance. G->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356860,PMID:17924331,PMID:23867111	
P38398	UniProtKB	Natural variant	1708	1708	.	.	.	ID=VAR_007796;Note=In BC%3B abolishes ACACA binding. A->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:23867111,ECO:0000269|PubMed:7939630;Dbxref=dbSNP:rs28897696,PMID:17924331,PMID:23867111,PMID:7939630	
P38398	UniProtKB	Natural variant	1713	1713	.	.	.	ID=VAR_007797;Note=V->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15365993;Dbxref=PMID:15365993	
P38398	UniProtKB	Natural variant	1715	1715	.	.	.	ID=VAR_063906;Note=In BC%3B unknown pathological significance. S->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80357094,PMID:17924331	
P38398	UniProtKB	Natural variant	1718	1718	.	.	.	ID=VAR_070503;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357239,PMID:23867111	
P38398	UniProtKB	Natural variant	1720	1720	.	.	.	ID=VAR_070504;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro%3B no effect on in vitro phosphorylation by ATR. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11114888,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs56195342,PMID:11114888,PMID:23867111	
P38398	UniProtKB	Natural variant	1735	1735	.	.	.	ID=VAR_070505;Note=In BC%3B unknown pathological significance. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs397509238,PMID:23867111	
P38398	UniProtKB	Natural variant	1736	1736	.	.	.	ID=VAR_070506;Note=In BC and FANCS%3B unknown pathological significance%3B Decreased localization to DNA damage sites and reduced interaction with UIMC1/RAP80. V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23269703,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs45553935,PMID:23269703,PMID:23867111	
P38398	UniProtKB	Natural variant	1738	1738	.	.	.	ID=VAR_063907;Note=In BC%3B unknown pathological significance. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80356937,PMID:17924331	
P38398	UniProtKB	Natural variant	1739	1739	.	.	.	ID=VAR_070507;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357227,PMID:23867111	
P38398	UniProtKB	Natural variant	1739	1739	.	.	.	ID=VAR_070508;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357227,PMID:23867111	
P38398	UniProtKB	Natural variant	1746	1746	.	.	.	ID=VAR_070509;Note=In BC%3B unknown pathological significance. H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs786202389,PMID:23867111	
P38398	UniProtKB	Natural variant	1749	1749	.	.	.	ID=VAR_007798;Note=In ovarian cancer%3B unknown pathological significance%3B abolishes ACACA binding and strongly reduces BRIP1 binding. P->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10486320,ECO:0000269|PubMed:11301010,ECO:0000269|PubMed:15133502;Dbxref=dbSNP:rs80357462,PMID:10486320,PMID:11301010,PMID:15133502	
P38398	UniProtKB	Natural variant	1753	1753	.	.	.	ID=VAR_070510;Note=In BC%3B unknown pathological significance. R->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs397509246,PMID:23867111	
P38398	UniProtKB	Natural variant	1764	1764	.	.	.	ID=VAR_063908;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357281,PMID:17924331,PMID:23867111	
P38398	UniProtKB	Natural variant	1766	1766	.	.	.	ID=VAR_063909;Note=In BC%3B unknown pathological significance. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80357463,PMID:17924331	
P38398	UniProtKB	Natural variant	1767	1767	.	.	.	ID=VAR_070511;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1770	1770	.	.	.	ID=VAR_070512;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs863224765,PMID:23867111	
P38398	UniProtKB	Natural variant	1775	1775	.	.	.	ID=VAR_063212;Note=In BC%3B strongly reduced transcription transactivation%3B abolishes interaction with BRIP1 and RBBP8. M->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18285836;Dbxref=dbSNP:rs41293463,PMID:18285836	
P38398	UniProtKB	Natural variant	1775	1775	.	.	.	ID=VAR_007799;Note=In BC%3B alters protein stability and abolishes ACACA and BRIP1 binding. M->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11301010,ECO:0000269|PubMed:12427738,ECO:0000269|PubMed:15133502,ECO:0000269|PubMed:7545954,ECO:0000269|PubMed:7939630;Dbxref=dbSNP:rs41293463,PMID:11301010,PMID:12427738,PMID:15133502,PMID:7545954,PMID:7939630	
P38398	UniProtKB	Natural variant	1776	1776	.	.	.	ID=VAR_008764;Note=In ovarian cancer%3B unknown pathological significance. P->S;Dbxref=dbSNP:rs1800757	
P38398	UniProtKB	Natural variant	1780	1780	.	.	.	ID=VAR_079607;Note=In BC%2C BROVCA1 and OC%3B unknown pathological significance. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28364669;Dbxref=dbSNP:rs80357474,PMID:28364669	
P38398	UniProtKB	Natural variant	1782	1782	.	.	.	ID=VAR_070513;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1786	1786	.	.	.	ID=VAR_020704;Note=In BROVCA1%3B unknown pathological significance. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs398122697,PMID:12938098	
P38398	UniProtKB	Natural variant	1788	1788	.	.	.	ID=VAR_063910;Note=In BC%3B unknown pathological significance. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80357069,PMID:17924331	
P38398	UniProtKB	Natural variant	1789	1789	.	.	.	ID=VAR_070514;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357078,PMID:23867111	
P38398	UniProtKB	Natural variant	1794	1794	.	.	.	ID=VAR_070515;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs397509275,PMID:23867111	
P38398	UniProtKB	Natural variant	1804	1804	.	.	.	ID=VAR_070516;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. V->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356920,PMID:23867111	
P38398	UniProtKB	Natural variant	1812	1812	.	.	.	ID=VAR_070517;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1812	1812	.	.	.	ID=VAR_008765;Note=In ovarian cancer%3B unknown pathological significance. P->S;Dbxref=dbSNP:rs1800751	
P38398	UniProtKB	Natural variant	1837	1837	.	.	.	ID=VAR_070518;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356959,PMID:23867111	
P38398	UniProtKB	Natural variant	1862	1862	.	.	.	ID=VAR_070519;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357183,PMID:23867111	
P38398	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Disrupts the interaction with E2 enzymes%2C thereby abolishing the E3 ubiquitin-protein ligase activity. I->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16818604,ECO:0000269|PubMed:20351172;Dbxref=PMID:16818604,PMID:20351172	
P38398	UniProtKB	Mutagenesis	26	26	.	.	.	Note=No ubiquitination of RBBP8. No restoration RBBP8-mediated focus formation or G2/M checkpoint control upon DNA damage. I->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16818604,ECO:0000269|PubMed:20351172;Dbxref=PMID:16818604,PMID:20351172	
P38398	UniProtKB	Mutagenesis	71	71	.	.	.	Note=No effect on interaction with BAP1. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9528852;Dbxref=PMID:9528852	
P38398	UniProtKB	Mutagenesis	308	308	.	.	.	Note=Abolishes phosphorylation by AURKA and interferes with cell cycle progression from G2 to mitosis. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14990569;Dbxref=PMID:14990569	
P38398	UniProtKB	Mutagenesis	1143	1143	.	.	.	Note=Reduces in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1239	1239	.	.	.	Note=No effect on in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1280	1280	.	.	.	Note=Reduces in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1298	1298	.	.	.	Note=No effect on in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1330	1330	.	.	.	Note=No effect on in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1387	1387	.	.	.	Note=Loss of IR-induced S-phase checkpoint. Reduces in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11114888,ECO:0000269|PubMed:12183412;Dbxref=PMID:11114888,PMID:12183412	
P38398	UniProtKB	Mutagenesis	1394	1394	.	.	.	Note=Reduces in vitro phosphorylation by ATR. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1423	1423	.	.	.	Note=Inhibition of the infrared-induced G2 arrest. Reduces phosphorylation by ATR. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11114888,ECO:0000269|PubMed:12183412;Dbxref=PMID:11114888,PMID:12183412	
P38398	UniProtKB	Mutagenesis	1457	1457	.	.	.	Note=Reduces in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1466	1466	.	.	.	Note=No effect on in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1524	1524	.	.	.	Note=No change in infrared S-phase delay%3B when associated with A-1387. No effect on in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11114888,ECO:0000269|PubMed:12183412;Dbxref=PMID:11114888,PMID:12183412	
P38398	UniProtKB	Mutagenesis	1655	1655	.	.	.	Note=Abolishes interaction with BRIP1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15133502;Dbxref=PMID:15133502	
P38398	UniProtKB	Mutagenesis	1656	1656	.	.	.	Note=No effect on affinity for a BRIP1 phosphopeptide. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21473589;Dbxref=PMID:21473589	
P38398	UniProtKB	Mutagenesis	1662	1662	.	.	.	Note=Does not abolish ABRAXAS1 binding%2C but abolishes formation of a heterotetramer with ABRAXAS1. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
P38398	UniProtKB	Mutagenesis	1663	1663	.	.	.	Note=Does not abolish ABRAXAS1 binding%2C but abolishes formation of a heterotetramer with ABRAXAS1. M->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
P38398	UniProtKB	Mutagenesis	1666	1666	.	.	.	Note=Does not abolish ABRAXAS1 binding%2C but impairs formation of a heterotetramer with ABRAXAS1. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
P38398	UniProtKB	Mutagenesis	1670	1670	.	.	.	Note=Impairs formation of a heterotetramer with ABRAXAS1. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
P38398	UniProtKB	Mutagenesis	1671	1671	.	.	.	Note=Impairs formation of a heterotetramer with ABRAXAS1. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
P38398	UniProtKB	Mutagenesis	1700	1700	.	.	.	Note=Strongly reduces affinity for a BRIP1 phosphopeptide. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21473589;Dbxref=PMID:21473589	
P38398	UniProtKB	Mutagenesis	1702	1702	.	.	.	Note=Abolishes interaction with BRIP1. K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15133502;Dbxref=PMID:15133502	
P38398	UniProtKB	Mutagenesis	1738	1738	.	.	.	Note=Abolishes interaction with BRIP1. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15133502;Dbxref=PMID:15133502	
P38398	UniProtKB	Mutagenesis	1755	1755	.	.	.	Note=No effect on in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1835	1835	.	.	.	Note=Mildly reduces affinity for a BRIP1 phosphopeptide. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21473589;Dbxref=PMID:21473589	
P38398	UniProtKB	Mutagenesis	1836	1836	.	.	.	Note=Slightly reduces affinity for a BRIP1 phosphopeptide. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21473589;Dbxref=PMID:21473589	
P38398	UniProtKB	Sequence conflict	89	89	.	.	.	Note=I->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Sequence conflict	148	148	.	.	.	Note=Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Sequence conflict	253	253	.	.	.	Note=A->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Sequence conflict	713	713	.	.	.	Note=S->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Sequence conflict	1077	1077	.	.	.	Note=G->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Sequence conflict	1426	1426	.	.	.	Note=S->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Sequence conflict	1527	1527	.	.	.	Note=E->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Helix	3	5	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Helix	8	21	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Beta strand	25	27	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Helix	46	53	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Beta strand	54	58	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Turn	62	64	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Turn	70	72	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Beta strand	78	80	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Helix	81	96	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Beta strand	1651	1656	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1659	1671	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1675	1679	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1T29	
P38398	UniProtKB	Beta strand	1686	1689	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1695	1697	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1701	1708	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1712	1715	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1717	1725	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1731	1734	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Turn	1740	1742	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1743	1745	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1T29	
P38398	UniProtKB	Helix	1748	1754	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Turn	1755	1757	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1T29	
P38398	UniProtKB	Turn	1760	1763	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1765	1768	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1770	1772	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1T2V	
P38398	UniProtKB	Beta strand	1773	1775	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1777	1786	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1790	1794	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1795	1797	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1801	1803	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1806	1810	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1812	1814	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1817	1819	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1OQA	
P38398	UniProtKB	Helix	1820	1822	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1824	1827	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1828	1830	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3PXE	
P38398	UniProtKB	Beta strand	1832	1834	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1835	1844	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1851	1853	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
